The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs)

References

• Chen J, Kim J, Dalton JT. (2005). Discovery and therapeutic promise of selective androgen receptor modulators. Mol Interv 5:173–188.
   PubMed Web of Science ®Google Scholar
• Dalton JT, Mukherjee A, Zhu Z, Kirkovsky L, Miller DD. (1998). Discovery of nonsteroidal androgens. Biochem Biophys Res Commun 244:1–4.
   PubMed Web of Science ®Google Scholar
• Gao W, Wu Z, Bohl CE, Yang J, Miller DD, Dalton JT. (2006). Characterization of the in vitro metabolism of selective androgen receptor modulator using human, rat, and dog liver enzyme preparations. Drug Metab Dispos 34:243–253.
   PubMed Web of Science ®Google Scholar
• Grata E, Perrenoud L, Saugy M, Baume N. (2011). SARM-S4 and metabolites detection in sports drug testing: A case report. Forensic Sci Int 213:104–108.
   PubMed Web of Science ®Google Scholar
• Krug O, Thomas A, Beuck S, Schenk I, Machnik M, Schänzer W, Bondesson U, Hedeland M, Thevis M. (2012). Characterization of in vitro synthesized equine metabolites of the selective androgen receptor modulators S24 and S4. J Equine Vet Sci 32:562–568.
   Google Scholar
• Kuuranne T, Leinonen A, Schänzer W, Kamber M, Kostiainen R, Thevis M. (2008). Aryl-propionamide-derived selective androgen receptor modulators: Liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes. Drug Metab Dispos 36:571–581.
   PubMed Web of Science ®Google Scholar
• Ma B, Huang HH, Chen XY, Sun YM, Lin LH, Zhong DF. (2007). Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana. Acta Pharmacol Sin 28:1067–1074.
   PubMed Web of Science ®Google Scholar
• Mohler ML, Nair VA, Hwang DJ, Rakov IM, Patil R, Miller DD. (2005). Nonsteroidal tissue selective androgen receptor modulators: A promising class of clinical candidates. Expert Opin Ther Pat 15:1565–1585.
   Web of Science ®Google Scholar
• Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD. (2009). Nonsteroidal selective androgen receptor modulators (SARMs): Dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem 52:3597–3617.
   PubMed Web of Science ®Google Scholar
• Pearce CM, Lushnikova MV. (2006). Microbiological production of omeprazole metabolites by Cunninghamella elegans. Journal of Molecular Catalysis B: Enzymatic 87–91.
   Google Scholar
• Rydevik A, Bondesson U, Hedeland M. (2012). Structural elucidation of phase I and II metabolites of bupivacaine in horse urine and fungi of the Cunninghamella species using liquid chromatography/multi-stage mass spectrometry. Rapid Commun Mass Spectrom 26:1338–1346.
   Google Scholar
• Tevell Åberg A, Olsson C, Bondesson U, Hedeland M. (2009). A mass spectrometric study on meloxicam metabolism in horses and the fungus Cunninghamella elegans, and the relevance of this microbial system as a model of drug metabolism in the horse. J Mass Spectrom 44:1026–1037.
   Google Scholar
• Tevell Åberg A, Loefgren H, Bondesson U, Hedeland M. (2010). Structural elucidation of Noxidized clemastine metabolites by liquid chromatography/tandem mass spectrometry and the use of Cunninghamella elegans to facilitate drug metabolite identification. Rapid Commun Mass Spectrom 24:1447–1456.
   Google Scholar
• Thevis M, Kamber M, Schänzer W. (2006). Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Commun Mass Spectrom 20:870–876.
   PubMed Web of Science ®Google Scholar
• Thevis M, Geyer H, Kamber M, Schänzer W. (2009). Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. Drug Test Anal 1:387–392.
   PubMed Web of Science ®Google Scholar
• Thevis M, Gerace E, Thomas A, Beuck S, Geyer H, Schlörer N, Kearbey JD, Dalton JT, Schänzer W. (2010a). Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. Drug Test Anal 2:589–598.
   Google Scholar
• Thevis M, Thomas A, Fusshöller G, Beuck S, Geyer H, Schänzer W. (2010b). Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. Rapid Commun Mass Spectrom 24:2245–2254.
   PubMed Web of Science ®Google Scholar
• Thevis M, Thomas A, Möller I, Geyer H, Dalton JT, Schänzer W. (2011). Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. Rapid Commun Mass Spectrom 25:2187–2195.
   PubMed Web of Science ®Google Scholar
• Wu D, Wu Z, Yang J, Nair VA, Miller DD, Dalton JT. (2006). Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: Implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic characteristics of a propanamide in preclinical study. Drug Metab Dispos 34:483–494.
   PubMed Web of Science ®Google Scholar
• Zhang D, Evans FE, Freeman JP, Duhart B Jr, Cerniglia CE. (1995). Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metab Dispos 23:1417–1425.
   PubMed Web of Science ®Google Scholar